Baroreflex Sensitivity Impairment Is Associated With Cardiac Diastolic Dysfunction in Rats

Carregando...
Imagem de Miniatura
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Citação
JOURNAL OF CARDIAC FAILURE, v.17, n.6, p.519-525, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Studies have shown that the autonomic dysfunction accompanied by impaired baroreflex sensitivity was associated with higher mortality. However, the influence of decreased baroreflex sensitivity on cardiac function, especially in diastolic function, is not well understood. This study evaluated the morpho-functional changes associated with baroreflex impairment induced by chronic sinoaortic denervation (SAD). Methods and Results: Animals were divided into sinoaortic denervation (SAD) and control (C) groups. Baroreflex sensitivity was evaluated by tachycardic and bradycardic responses, induced by vasoactive drugs. Cardiac function was studied by echocardiography and by left ventricle (LV) catheterization. LV collagen content and the expression of regulatory proteins involved in intracellular Ca(2+) homeostasis were quantified. Results showed higher LV mass in SAD versus C animals. Furthermore, an increase in deceleration time of E-wave in the SAD versus the C group (2.14 +/- 0.07 ms vs 1.78 +/- 0.03 ms) was observed. LV end-diastolic pressure was increased and the minimum dP/dt was decreased in the SAD versus the C group (12 +/- 1.5 mm Hg vs 5.3 +/- 0.2 mm Hg and 7,422 +/- 201 vs 4,999 +/- 345 mm Hg/s, respectively). SERCA/NCX ratio was lower in SAD than in control rats. The same was verified in SERCA/PLB ratio. Conclusions: The results suggest that baroreflex dysfunction is associated with cardiac diastolic dysfunction independently of the presence of other risk factors. (J Cardiac Fail 2011;17:519-525)
Palavras-chave
Baroreflex, diastolic function, cardiac hypertrophy, intracellular Ca(2+)
Referências
  1. IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111
  2. Brum PC, 2006, AN ACAD BRAS CIENC, V78, P485, DOI 10.1590/S0001-37652006000300009
  3. Martinka P, 2005, AM J PHYSIOL-REG I, V288, pR767, DOI 10.1152/ajpregu.00445.2004
  4. La Rovere MT, 2009, J AM COLL CARDIOL, V53, P193, DOI 10.1016/j.jacc.2008.09.034
  5. Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
  6. Van Vliet BN, 1999, J PHYSIOL-LONDON, V516, P885
  7. Grassi G, 2010, HYPERTENS RES, V33, P381, DOI 10.1038/hr.2010.26
  8. Post SR, 1999, ANNU REV PHARMACOL, V39, P343, DOI 10.1146/annurev.pharmtox.39.1.343
  9. Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007
  10. Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x
  11. Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88
  12. Grassi G, 2009, HYPERTENSION, V53, P205, DOI 10.1161/HYPERTENSIONAHA.108.121467
  13. KRIEGER EM, 1964, CIRC RES, V15, P511
  14. Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010
  15. Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002
  16. Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x
  17. Liu AJ, 2007, STROKE, V38, P1916, DOI 10.1161/STROKEAHA.106.480061
  18. Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010
  19. Kudo H, 2009, HYPERTENSION, V54, P832, DOI 10.1161/HYPERTENSIONAHA.109.135905
  20. Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745
  21. Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JC125397
  22. Bai Xufang, 2008, Open Cardiovasc Med J, V2, P9, DOI 10.2174/1874192400802010009
  23. Biaggioni I, 2007, AM J MED SCI, V334, P61, DOI 10.1097/MAJ.0b013e318065c03b
  24. Braga LMGD, 2008, J BIOMED SCI, V15, P365, DOI 10.1007/s11373-008-9237-z
  25. Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001
  26. La Rovere MT, 1998, LANCET, V351, P478
  27. NEUMANN J, 1993, AM J PHYSIOL, V265, pH257
  28. SASAKI S, 1994, AM J HYPERTENS, V7, P453
  29. Senzaki H, 1999, J AM COLL CARDIOL, V34, P1529, DOI 10.1016/S0735-1097(99)00362-9
  30. Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002
  31. Stern Javier E., 1994, Biological Signals, V3, P15